Connect
MJA
MJA

Infectious diseases in Australia — the next decade

Thomas Gottlieb, Bart J Currie and David F M Looke, on behalf of the Executive Council of the Australasian Society for Infectious Diseases
Med J Aust 2012; 196 (5): 292-293. || doi: 10.5694/mja12.10116
Published online: 19 March 2012

We need high-voltage infection prevention and management, not short-sighted overuse of antibiotics

As long as human behaviour and medical practices exert unpredictable effects on the microbial environment, infectious disease will continue to challenge and surprise us. Changes in host factors (eg, immunosuppression, hospitalisation), environment (eg, air travel, global warming), and adaptations of microbial pathogens (eg, HIV and severe acute respiratory syndrome [SARS]) can have unanticipated effects. Stated another way, microbial Darwinism is at play.

  • Thomas Gottlieb1
  • Bart J Currie2
  • David F M Looke3
  • on behalf of the Executive Council of the Australasian Society for Infectious Diseases

  • 1 Concord Hospital, Sydney, NSW.
  • 2 Tropical and Emerging Infectious Diseases, Menzies School of Health Research, Darwin, NT.
  • 3 Princess Alexandra Hospital, Brisbane, QLD.


Competing interests:

Thomas Gottlieb is President of the Australasian Society for Infectious Diseases. He has served on advisory boards for Novartis, Pfizer, AstraZeneca, bioMérieux and Janssen-Cilag. Bart Currie is a member of the Executive Council of the Australasian Society for Infectious Diseases. David Looke is Vice-President of the Australasian Society for Infectious Diseases.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.